Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis, and anticancer evaluation of novel quinoline derivatives of ursolic acid with hydrazide, oxadiazole, and thiadiazole moieties as potent MEK inhibitors
Xiaoyan Jin, Hao Chen, Dong‐Dong Li, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2019) Vol. 34, Iss. 1, pp. 955-972
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Ursolic Acid-Based Derivatives as Potential Anti-Cancer Agents: An Update
Vuyolwethu Khwaza, Opeoluwa O. Oyedeji, Blessing A. Aderibigbe
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5920-5920
Open Access | Times Cited: 140
Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective
Adarsh Kumar, Ankit Kumar Singh, Harshwardhan Singh, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 299-299
Open Access | Times Cited: 121
Concept of Hybrid Drugs and Recent Advancements in Anticancer Hybrids
Ankit Kumar Singh, Adarsh Kumar, Harshwardhan Singh, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 9, pp. 1071-1071
Open Access | Times Cited: 94
1,3,4-Oxadiazole-containing hybrids as potential anticancer agents: Recent developments, mechanism of action and structure-activity relationships
Swarnagowri Nayak, Santosh L. Gaonkar, Ebraheem Abdu Musad, et al.
Journal of Saudi Chemical Society (2021) Vol. 25, Iss. 8, pp. 101284-101284
Open Access | Times Cited: 70
Computational targeting of allosteric site of MEK1 by quinoline‐based molecules
Rahul Singh, Vijay Kumar Bhardwaj, Rituraj Purohit
Cell Biochemistry and Function (2022) Vol. 40, Iss. 5, pp. 481-490
Closed Access | Times Cited: 58
Caspase-3 Activators as Anticancer Agents
Nitin Srivastava, Anil K. Saxena
Current Protein and Peptide Science (2023) Vol. 24, Iss. 10, pp. 783-804
Closed Access | Times Cited: 21
Application of Quinoline Ring in Structural Modification of Natural Products
Yuqing Zhao, Xiaoting Li, Hongyan Guo, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6478-6478
Open Access | Times Cited: 20
Nitrogen-fused Heterocycles: Empowering Anticancer Drug Discovery
Tanya Biswas, Ravi K. Mittal, Vikram Sharma, et al.
Medicinal Chemistry (2024) Vol. 20, Iss. 4, pp. 369-384
Closed Access | Times Cited: 6
Discovery of 4-alkoxy-2-aryl-6,7-dimethoxyquinolines as a new class of topoisomerase I inhibitors endowed with potent in vitro anticancer activity
Mostafa M. Elbadawi, Wagdy M. Eldehna, Wenjie Wang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 215, pp. 113261-113261
Open Access | Times Cited: 39
The Versatile Quinoline and Its Derivatives as anti-Cancer Agents: An Overview
Basavarajaiah Suliphuldevara Mathada
Polycyclic aromatic compounds (2022) Vol. 43, Iss. 5, pp. 4333-4345
Closed Access | Times Cited: 34
Ursolic acid: a natural modulator of signaling networks in different cancers
Sameen Zafar, Khushbukhat Khan, Amna Hafeez, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 31
Friedlӓnder's synthesis of quinolines as a pivotal step in the development of bioactive heterocyclic derivatives in the current era of medicinal chemistry
Rajendran Satheeshkumar, Kalaiselvi Sivalingam, Karnam Jayarampillai Rajendra Prasad, et al.
Chemical Biology & Drug Design (2022) Vol. 100, Iss. 6, pp. 1042-1085
Closed Access | Times Cited: 30
MEK inhibitors in cancer treatment: structural insights, regulation, recent advances and future perspectives
Teja Ram, Ankit Kumar Singh, Adarsh Kumar, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 10, pp. 1837-1857
Open Access | Times Cited: 17
Therapeutic Potential of Ursonic Acid: Comparison with Ursolic Acid
Juhyeon Son, Sang Yeol Lee
Biomolecules (2020) Vol. 10, Iss. 11, pp. 1505-1505
Open Access | Times Cited: 47
Quinoline-Based Molecules Targeting c-Met, EGF, and VEGF Receptors and the Proteins Involved in Related Carcinogenic Pathways
Annamaria Martorana, Gabriele La Monica, Antonino Lauria
Molecules (2020) Vol. 25, Iss. 18, pp. 4279-4279
Open Access | Times Cited: 46
Have molecular hybrids delivered effective anti-cancer treatments and what should future drug discovery focus on?
Shalini Shalini, Vipan Kumar
Expert Opinion on Drug Discovery (2020) Vol. 16, Iss. 4, pp. 335-363
Closed Access | Times Cited: 39
An overview of recent advancements in small molecules suppression of oncogenic signaling of K-RAS: an updated review
Ahmed Sabt, Haytham O. Tawfik, Eman F. Khaleel, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 3
An Update on Pentacyclic Triterpenoids Ursolic and Oleanolic Acids and Related Derivatives as Anticancer Candidates
Diana Similie, Daliana Minda, Larisa Bora, et al.
Antioxidants (2024) Vol. 13, Iss. 8, pp. 952-952
Open Access | Times Cited: 3
Synthesis of ursolic acid arylidene-hydrazide hybrid compounds and investigation of their cytotoxic and antimicrobial effects
Halil Şenol, Rabia Büşra Şahin, Mercümek Berre, et al.
Natural Product Research (2022) Vol. 37, Iss. 15, pp. 2500-2507
Open Access | Times Cited: 20
Synthesis of oleanolic acid hydrazide-hydrazone hybrid derivatives and investigation of their cytotoxic effects on A549 human lung cancer cells
Halil Şenol, Mercümek Berre, Şahin Rabia Büşra, et al.
Results in Chemistry (2022) Vol. 4, pp. 100317-100317
Open Access | Times Cited: 19
Catharanthus roseus Combined with Ursolic Acid Attenuates Streptozotocin-Induced Diabetes through Insulin Secretion and Glycogen Storage
Huda M. Alkreathy, Aftab Ahmad
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-8
Open Access | Times Cited: 28
New Potential Agents for Malignant Melanoma Treatment—Most Recent Studies 2020–2022
Paweł Kozyra, Danuta Krasowska, Monika Pitucha
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6084-6084
Open Access | Times Cited: 16
Quinoline-based Anti-oncogenic Molecules: Synthesis and Biological Evaluation
Shivangi Sharma, Shivendra Singh, Dhananjay Yadav
Medicinal Chemistry (2023) Vol. 19, Iss. 9, pp. 848-858
Closed Access | Times Cited: 8
New heterocyclic azo-disperse dyes; their synthesis, characterization, application, photo physical properties and solvatochromic studies
Muhammad Salman, Abdul Jabbar, Salma Zainab Farooq, et al.
Journal of Molecular Structure (2023) Vol. 1287, pp. 135664-135664
Closed Access | Times Cited: 8
Potential Pharmacological Properties of Triterpene Derivatives of Ursolic Acid
Vuyolwethu Khwaza, Blessing A. Aderibigbe
Molecules (2024) Vol. 29, Iss. 16, pp. 3884-3884
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top